The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndrome

References

• El-Salhy M. Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol. 2012;18:5151–5163.
   PubMed Web of Science ®Google Scholar
• El-Salhy M. Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol. 2015;21:7621–7636.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gundersen D, Hatlebakk JG, et al. Irritable bowel syndrome: diagnosis, pathogenesis and treatment options. New York: Nova Science Publishers, Inc.; 2012.
   Google Scholar
• Isgar B, Harman M, Kaye MD, et al. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut. 1983;24:190–192.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gundersen D, Gilja OH, et al. Is irritable bowel syndrome an organic disorder? World J Gastroenterol. 2014;20:384–400.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Hatlebakk JG, Gilja OH, et al. Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment. Expert Rev Gastroenterol Hepatol. 2014;8:435–443.
   PubMed Web of Science ®Google Scholar
• Ansari R, Attari F, Razjouyan H, et al. Ulcerative colitis and irritable bowel syndrome: relationships with quality of life. Eur J Gastroenterol Hepatol. 2008;20:46–50.
   PubMed Web of Science ®Google Scholar
• Simren M, Axelsson J, Gillberg R, et al. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol. 2002;97:389–396.
   PubMed Web of Science ®Google Scholar
• Keohane J, O’Mahony C, O’Mahony L, et al. Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation? Am J Gastroenterol. 2010;105:1788, 1789–1794; quiz 1795.
   Web of Science ®Google Scholar
• Minderhoud IM, Oldenburg B, Wismeijer JA, et al. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci. 2004;49:469–474.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Hatlebakk JG, Gilja OH, et al. The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome. Nutr J. 2015;14:92.
   PubMed Web of Science ®Google Scholar
• Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38:1569–1580.
   PubMed Web of Science ®Google Scholar
• Agreus L, Svardsudd K, Nyren O, et al. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995;109:671–680.
   PubMed Web of Science ®Google Scholar
• Talley NJ, Gabriel SE, Harmsen WS, et al. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology. 1995;109:1736–1741.
   PubMed Web of Science ®Google Scholar
• Harvey RF, Mauad EC, Brown AM. Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet. 1987;1:963–965.
   PubMed Web of Science ®Google Scholar
• Sloth H, Jorgensen LS. Chronic non-organic upper abdominal pain: diagnostic safety and prognosis of gastrointestinal and non-intestinal symptoms. A 5- to 7-year follow-up study. Scand J Gastroenterol. 1988;23:1275–1280.
   PubMed Web of Science ®Google Scholar
• Xiong LS, Chen MH, Chen HX, et al. A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling. Aliment Pharmacol Ther. 2004;19:1217–1224.
   PubMed Web of Science ®Google Scholar
• Gralnek IM, Hays RD, Kilbourne A, et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000;119:654–660.
   PubMed Web of Science ®Google Scholar
• Gralnek IM, Hays RD, Kilbourne AM, et al. Racial differences in the impact of irritable bowel syndrome on health-related quality of life. J Clin Gastroenterol. 2004;38:782–789.
   PubMed Web of Science ®Google Scholar
• Whitehead WE, Burnett CK, Cook EW 3rd, et al. Impact of irritable bowel syndrome on quality of life. Dig Dis Sci. 1996;41:2248–2253.
   PubMed Web of Science ®Google Scholar
• Arasaradnam RP, Westenbrink E, McFarlane MJ, et al. Differentiating coeliac disease from irritable bowel syndrome by urinary volatile organic compound analysis - a pilot study. PloS One. 2014;9:e107312.
   PubMed Web of Science ®Google Scholar
• Barbara G, Stanghellini V. Biomarkers in IBS: when will they replace symptoms for diagnosis and management? Gut. 2009;58:1571–1575.
   PubMed Web of Science ®Google Scholar
• Spiller RC. Potential biomarkers. Gastroenterol Clin North Am. 2011;40:121–139.
   PubMed Web of Science ®Google Scholar
• Palsson OS, Whitehead WE, van Tilburg MA, et al. Rome IV Diagnostic Questionnaires and Tables for Investigators and Clinicians. Gastroenterology. 2016;150:1481–1491.
   Web of Science ®Google Scholar
• Longstreth GF. Definition and classification of irritable bowel syndrome: current consensus and controversies. Gastroenterol Clin North Am. 2005;34:173–187.
   PubMed Web of Science ®Google Scholar
• Spiller R, Aziz Q, Creed F, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut. 2007;56:1770–1798.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Mazzawi T, Umezawa K, et al. Enteroendocrine cells, stem cells and differentiation progenitors in rats with TNBS-induced colitis. Int J Mol Med. 2016;38:1743–1751.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Seim I, Chopin L, et al. Irritable bowel syndrome: the role of gut neuroendocrine peptides. Front Biosci (Elite Ed). 2012;4:2783–2800.
   PubMedGoogle Scholar
• Sandstrom O, El-Salhy M. Ageing and endocrine cells of human duodenum. Mech Ageing Dev. 1999;108:39–48.
   PubMed Web of Science ®Google Scholar
• El-Salhy M. Ghrelin in gastrointestinal diseases and disorders: a possible role in the pathophysiology and clinical implications (review). Int J Mol Med. 2009;24:727–732.
   PubMed Web of Science ®Google Scholar
• Tolhurst G, Reimann F, Gribble FM. Intestinal sensing of nutrients. Handb Exp Pharmacol. 2012;209:309–335.
   PubMedGoogle Scholar
• Lee J, Cummings BP, Martin E, et al. Glucose sensing by gut endocrine cells and activation of the vagal afferent pathway is impaired in a rodent model of type 2 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol. 2012;302:R657–R666.
   PubMed Web of Science ®Google Scholar
• Parker HE, Reimann F, Gribble FM. Molecular mechanisms underlying nutrient-stimulated incretin secretion. Expert Rev Mol Med. 2010;12:e1.
   PubMed Web of Science ®Google Scholar
• Raybould HE. Nutrient sensing in the gastrointestinal tract: possible role for nutrient transporters. J Physiol Biochem. 2008;64:349–356.
   PubMed Web of Science ®Google Scholar
• San Gabriel A, Nakamura E, Uneyama H, et al. Taste, visceral information and exocrine reflexes with glutamate through umami receptors. J Med Invest. 2009;56(Suppl):209–217.
   PubMedGoogle Scholar
• Rudholm T, Wallin B, Theodorsson E, et al. Release of regulatory gut peptides somatostatin, neurotensin and vasoactive intestinal peptide by acid and hyperosmolal solutions in the intestine in conscious rats. Regul Pept. 2009;152:8–12.
   PubMedGoogle Scholar
• Sternini C, Anselmi L, Rozengurt E. Enteroendocrine cells: a site of ‘taste’ in gastrointestinal chemosensing. Curr Opin Endocrinol Diabetes Obes. 2008;15:73–78.
   PubMed Web of Science ®Google Scholar
• Sternini C. Taste receptors in the gastrointestinal tract. IV. Functional implications of bitter taste receptors in gastrointestinal chemosensing. Am J Physiol Gastrointest Liver Physiol. 2007;292:G457–G461.
   PubMed Web of Science ®Google Scholar
• Buchan AM. Nutrient Tasting and Signaling Mechanisms in the Gut III. Endocrine cell recognition of luminal nutrients. Am J Physiol. 1999;277:G1103–G1107.
   PubMed Web of Science ®Google Scholar
• Montero-Hadjadje M, Elias S, Chevalier L, et al. Chromogranin a promotes peptide hormone sorting to mobile granules in constitutively and regulated secreting cells: role of conserved N- and C-terminal peptides. J Biol Chem. 2009;284:12420–12431.
   PubMed Web of Science ®Google Scholar
• Shooshtarizadeh P, Zhang D, Chich JF, et al. The antimicrobial peptides derived from chromogranin/secretogranin family, new actors of innate immunity. Regul Pept. 2010;165:102–110.
   PubMedGoogle Scholar
• Reber SO, Obermeier F, Straub RH, et al. Chronic intermittent psychosocial stress (social defeat/overcrowding) in mice increases the severity of an acute DSS-induced colitis and impairs regeneration. Endocrinology. 2006;147(10):4968–4976.
   PubMed Web of Science ®Google Scholar
• Milde AM, Murison R. A study of the effects of restraint stress on colitis induced by dextran sulphate sodium in singly housed rats. Integr Physiol Behav Sci. 2002;37(2):140–150.
   PubMed Web of Science ®Google Scholar
• Furness JB, Kunze WA, Clerc N. Nutrient tasting and signaling mechanisms in the gut. II. The intestine as a sensory organ: neural, endocrine, and immune responses. Am J Physiol. 1999;277:G922–928.
   PubMed Web of Science ®Google Scholar
• Hassani H, Lucas G, Rozell B, et al. Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling. Am J Physiol Gastrointest Liver Physiol. 2005;288(3):G550–556.
   PubMed Web of Science ®Google Scholar
• Cani PD, Everard A, Duparc T. Gut microbiota, enteroendocrine functions and metabolism. Curr Opin Pharmacol. 2013;13:935–940.
   PubMed Web of Science ®Google Scholar
• Cani PD, Hoste S, Guiot Y, et al. Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr. 2007;98:32–37.
   PubMed Web of Science ®Google Scholar
• Petitto JM, Huang Z, McCarthy DB. Molecular cloning of NPY-Y1 receptor cDNA from rat splenic lymphocytes: evidence of low levels of mRNA expression and [125I]NPY binding sites. J Neuroimmunol. 1994;54(1–2):81–86.
   PubMed Web of Science ®Google Scholar
• De La Fuente M, Bernaez I, Del Rio M, et al. Stimulation of murine peritoneal macrophage functions by neuropeptide Y and peptide YY. Involvement of protein kinase C. Immunology. 1993;80(2):259–265.
   PubMed Web of Science ®Google Scholar
• Shibata M, Hisajima T, Nakano M, et al. Morphological relationships between peptidergic nerve fibers and immunoglobulin A-producing lymphocytes in the mouse intestine. Brain Behav Immun. 2008;22(2):158–166.
   PubMed Web of Science ®Google Scholar
• Painsipp E, Herzog H, Sperk G, et al. Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide Y. Br J Pharmacol. 2011;163(6):1302–1314.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Grimelius L, Wilander E, et al. Histological and immunohistochemical studies of the endocrine cells of the gastrointestinal mucosa of the toad (Bufo regularis). Histochemistry. 1981;71:53–65.
   PubMedGoogle Scholar
• Sandstrom O. Age-related changes in the neuroendocrine system of the gut. Umea Univ Med Diss. 1999;617:1–46.
   Google Scholar
• Bohorquez DV, Chandra R, Samsa LA, et al. Characterization of basal pseudopod-like processes in ileal and colonic PYY cells. J Mol Histol. 2011;42:3–13.
   PubMed Web of Science ®Google Scholar
• Gustafsson BI, Bakke I, Hauso O, et al. Parietal cell activation by arborization of ECL cell cytoplasmic projections is likely the mechanism for histamine induced secretion of hydrochloric acid. Scand J Gastroenterol. 2011;46:531–537.
   PubMed Web of Science ®Google Scholar
• Gustafsson BI, Bakke I, Tommeras K, et al. A new method for visualization of gut mucosal cells, describing the enterochromaffin cell in the rat gastrointestinal tract. Scand J Gastroenterol. 2006;41:390–395.
   PubMed Web of Science ®Google Scholar
• Pang XH, Li TK, Xie Q, et al. Amelioration of dextran sulfate sodium-induced colitis by neuropeptide Y antisense oligodeoxynucleotide. Int J Colorectal Dis. 2010;25(9):1047–1053.
   PubMed Web of Science ®Google Scholar
• Bohorquez DV, Samsa LA, Roholt A, et al. An enteroendocrine cell-enteric glia connection revealed by 3D electron microscopy. PloS One. 2014;9:e89881.
   PubMed Web of Science ®Google Scholar
• Bohorquez DV, Shahid RA, Erdmann A, et al. Neuroepithelial circuit formed by innervation of sensory enteroendocrine cells. J Clin Invest. 2015;125:782–786.
   PubMed Web of Science ®Google Scholar
• Rindi G, Inzani F, Solcia E. Pathology of gastrointestinal disorders. Endocrinol Metab Clin North Am. 2010;39:713–727.
   PubMed Web of Science ®Google Scholar
• Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest. 2007;117:13–23.
   PubMed Web of Science ®Google Scholar
• Bertrand PP. The cornucopia of intestinal chemosensory transduction. Front Neurosci. 2009;3:48.
   PubMed Web of Science ®Google Scholar
• Bertrand PP, Bertrand RL. Serotonin release and uptake in the gastrointestinal tract. Auton Neurosci. 2010;153:47–57.
   PubMed Web of Science ®Google Scholar
• Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 2007;132:397–414.
   PubMed Web of Science ®Google Scholar
• Gershon MD. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2013;20:14–21.
   PubMed Web of Science ®Google Scholar
• Ghia JE, Li N, Wang H, et al. Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology. 2009;137:1649–1660.
   PubMed Web of Science ®Google Scholar
• Walther DJ, Peter JU, Bashammakh S, et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science. 2003;299:76.
   PubMed Web of Science ®Google Scholar
• Gutknecht L, Kriegebaum C, Waider J, et al. Spatio-temporal expression of tryptophan hydroxylase isoforms in murine and human brain: convergent data from Tph2 knockout mice. Eur Neuropsychopharmacol. 2009;19:266–282.
   PubMed Web of Science ®Google Scholar
• Neal KB, Parry LJ, Bornstein JC. Strain-specific genetics, anatomy and function of enteric neural serotonergic pathways in inbred mice. J Physiol. 2009;587:567–586.
   PubMed Web of Science ®Google Scholar
• Tack JF, Janssens J, Vantrappen G, et al. Actions of 5-hydroxytryptamine on myenteric neurons in guinea pig gastric antrum. Am J Physiol. 1992;263:G838–G846.
   PubMed Web of Science ®Google Scholar
• Michel K, Sann H, Schaaf C, et al. Subpopulations of gastric myenteric neurons are differentially activated via distinct serotonin receptors: projection, neurochemical coding, and functional implications. J Neurosci. 1997;17:8009–8017.
   PubMed Web of Science ®Google Scholar
• Tack J, Coulie B, Wilmer A, et al. Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut. 2000;46:468–473.
   PubMed Web of Science ®Google Scholar
• Grundy D, Hillsley K, Kirkup AJ, et al. Mesenteric afferent sensitivity to cholecystokinin and 5-hydroxytryptamine. Dtsch Tierarztl Wochenschr. 1998;105:466–468.
   PubMedGoogle Scholar
• Hillsley K, Grundy D. Sensitivity to 5-hydroxytryptamine in different afferent subpopulations within mesenteric nerves supplying the rat jejunum. J Physiol. 1998;509(Pt 3):717–727.
   PubMed Web of Science ®Google Scholar
• Hillsley K, Kirkup AJ, Grundy D. Direct and indirect actions of 5-hydroxytryptamine on the discharge of mesenteric afferent fibres innervating the rat jejunum. J Physiol. 1998;506(Pt 2):551–561.
   PubMed Web of Science ®Google Scholar
• Blackshaw LA, Grundy D. Effects of 5-hydroxytryptamine (5-HT) on the discharge of vagal mechanoreceptors and motility in the upper gastrointestinal tract of the ferret. J Auton Nerv Syst. 1993;45:51–59.
   PubMedGoogle Scholar
• Kirchgessner AL, Liu MT, Gershon MD. In situ identification and visualization of neurons that mediate enteric and enteropancreatic reflexes. J Comp Neurol. 1996;371:270–286.
   PubMed Web of Science ®Google Scholar
• Kirchgessner AL, Liu MT, Tamir H, et al. Identification and localization of 5-HT1P receptors in the guinea pig pancreas. Am J Physiol. 1992;262:G553–G566.
   PubMed Web of Science ®Google Scholar
• Pan H, Gershon MD. Activation of intrinsic afferent pathways in submucosal ganglia of the guinea pig small intestine. J Neurosci. 2000;20:3295–3309.
   PubMed Web of Science ®Google Scholar
• Cooke HJ, Sidhu M, Wang YZ. 5-HT activates neural reflexes regulating secretion in the guinea-pig colon. Neurogastroenterol Motil. 1997;9:181–186.
   PubMed Web of Science ®Google Scholar
• Spangeus A, Forsgren S, el-Salhy M. Does diabetic state affect co-localization of peptide YY and enteroglucagon in colonic endocrine cells? Histol Histopathol. 2000;15:37–41.
   PubMed Web of Science ®Google Scholar
• Pyarokhil AH, Ishihara M, Sasaki M, et al. The developmental plasticity of colocalization pattern of peptide YY and glucagon-like peptide-1 in the endocrine cells of bovine rectum. Biomed Res. 2012;33:35–38.
   PubMed Web of Science ®Google Scholar
• Mortensen K, Christensen LL, Holst JJ, et al. GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regul Pept. 2003;114:189–196.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Wilander E, Grimelius L. Immunocytochemical localization of gastric inhibitory peptide (GIP) in the human foetal pancreas. Ups J Med Sci. 1982;87:81–85.
   PubMed Web of Science ®Google Scholar
• Wendelbo I, Mazzawi T, El-Salhy M. Increased serotonin transporter immunoreactivity intensity in the ileum of patients with irritable bowel disease. Mol Med Rep. 2014;9:180–184.
   PubMed Web of Science ®Google Scholar
• Dizdar V, Spiller R, Singh G, et al. Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced post-infectious irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther. 2010;31:883–891.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gilja OH, Gundersen D, et al. Duodenal chromogranin a cell density as a biomarker for the diagnosis of irritable bowel syndrome. Gastroenterol Res Pract. 2014;462856:2014.
   Google Scholar
• El-Salhy M, Gilja OH, Gundersen D, et al. Endocrine cells in the ileum of patients with irritable bowel syndrome. World J Gastroenterol. 2014;20:2383–2391.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gilja OH, Gundersen D, et al. Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome. World J Gastrointest Endosc. 2014;6:176–185.
   PubMedGoogle Scholar
• El-Salhy M, Gilja OH, Hatlebakk JG, et al. Stomach antral endocrine cells in patients with irritable bowel syndrome. Int J Mol Med. 2014;34:967–974.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gilja OH, Hausken T. Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome. Mol Med Rep. 2014;10:1753–1757.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gundersen D, Hatlebakk JG, et al. Abnormal rectal endocrine cells in patients with irritable bowel syndrome. Regul Pept. 2014;188:60–65.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gundersen D, Ostgaard H, et al. Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome. Dig Dis Sci. 2012;57:873–878.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Hatlebakk JG, Gilja OH, et al. Densities of rectal peptide YY and somatostatin cells as biomarkers for the diagnosis of irritable bowel syndrome. Regul Pept. Forthcoming 2015;67:12–19.
   Google Scholar
• El-Salhy M, Lillebo E, Reinemo A, et al. Ghrelin in patients with irritable bowel syndrome. Int J Mol Med. 2009;23:703–707.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Wendelbo I, Gundersen D. Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome. Mol Med Report. 2013;7:1241–1244.
   PubMed Web of Science ®Google Scholar
• Sjolund K, Ekman R, Wierup N. Covariation of plasma ghrelin and motilin in irritable bowel syndrome. Peptides. 2010;31:1109–1112.
   PubMed Web of Science ®Google Scholar
• Wang H, Steeds J, Motomura Y, et al. CD4+ T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection. Gut. 2007;56:949–957.
   PubMed Web of Science ®Google Scholar
• Wang SH, Dong L, Luo JY, et al. Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. World J Gastroenterol. 2007;13:6041–6047.
   PubMed Web of Science ®Google Scholar
• Park JH, Rhee PL, Kim G, et al. Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome. Neurogastroenterol Motil. 2006;18:539–546.
   PubMed Web of Science ®Google Scholar
• Coates MD, Mahoney CR, Linden DR, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology. 2004;126:1657–1664.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Mazzawi T, Hausken T, et al. Interaction between diet and gastrointestinal endocrine cells. Biomed Reports. 2016;4:651–656.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Mazzawi T, Gundersen D, et al. The role of peptide YY in gastrointestinal diseases and disorders (Review). Int J Mol Med. 2013;31:275–282.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Mazzawi T, Gundersen D, et al. Chromogranin A cell density in the rectum of patients with irritable bowel syndrome. Mol Med Report. 2012;6:1223–1225.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Lomholt-Beck B, Hausken T. Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome. Scand J Gastroenterol. 2010;45:1435–1439.
   PubMed Web of Science ®Google Scholar
• Cardoso WV, Lu J. Regulation of early lung morphogenesis: questions, facts and controversies. Development. 2006;133:1611–1624.
   PubMed Web of Science ®Google Scholar
• Darlington GJ. Molecular mechanisms of liver development and differentiation. Curr Opin Cell Biol. 1999;11:678–682.
   PubMed Web of Science ®Google Scholar
• Rawlins EL, Hogan BL. Ciliated epithelial cell lifespan in the mouse trachea and lung. Am J Physiol Lung Cell Mol Physiol. 2008;295:L231–L234.
   PubMed Web of Science ®Google Scholar
• Zaret KS. Regulatory phases of early liver development: paradigms of organogenesis. Nat Rev Genet. 2002;3:499–512.
   PubMed Web of Science ®Google Scholar
• Barker N, Clevers H. Tracking down the stem cells of the intestine: strategies to identify adult stem cells. Gastroenterology. 2007;133:1755–1760.
   PubMed Web of Science ®Google Scholar
• Barker N, van de Wetering M, Clevers H. The intestinal stem cell. Genes Dev. 2008;22:1856–1864.
   PubMed Web of Science ®Google Scholar
• Barker N, Van Es JH, Kuipers J, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449:1003–1007.
   PubMed Web of Science ®Google Scholar
• Barker N, Van Oudenaarden A, Clevers H. Identifying the stem cell of the intestinal crypt: strategies and pitfalls. Cell Stem Cell. 2012;11(4):452–460.
   PubMed Web of Science ®Google Scholar
• Cheng H, Leblond CP. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. Am J Anat. 1974;141:537–561.
   PubMedGoogle Scholar
• Fontaine J, Le Lievre C, Le Douarin NM. What is the developmental fate of the neural crest cells which migrate into the pancreas in the avian embryo? Gen Comp Endocrinol. 1977;33:394–404.
   PubMed Web of Science ®Google Scholar
• Le Douarin NM, Teillet MA. The migration of neural crest cells to the wall of the digestive tract in avian embryo. J Embryol Exp Morphol. 1973;30:31–48.
   PubMedGoogle Scholar
• Montgomery RK, Breault DT. Small intestinal stem cell markers. J Anat. 2008;213:52–58.
   PubMed Web of Science ®Google Scholar
• Roberts SA, Hendry JH, Potten CS. Intestinal crypt clonogens: a new interpretation of radiation survival curve shape and clonogenic cell number. Cell Prolif. 2003;36(4):215–231.
   PubMed Web of Science ®Google Scholar
• Kayahara T, Sawada M, Takaishi S, et al. Candidate markers for stem and early progenitor cells, Musashi-1 and Hes1, are expressed in crypt base columnar cells of mouse small intestine. FEBS Lett. 2003;535:131–135.
   PubMed Web of Science ®Google Scholar
• He XC, Yin T, Grindley JC, et al. PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat Genet. 2007;39:189–198.
   PubMed Web of Science ®Google Scholar
• Lopez-Diaz L, Jain RN, Keeley TM, et al. Intestinal Neurogenin 3 directs differentiation of a bipotential secretory progenitor to endocrine cell rather than goblet cell fate. Dev Biol. 2007;309:298–305.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Hatlebakk JG, Hausken T. The reduction in duodenal endocrine cells in IBSis associated with stem cell abnormalities. World J Gastroenterol. 2015;21:9577–9587.
   PubMed Web of Science ®Google Scholar
• El-Sahy M, Gilja OH. Abnormal ileal stem-, neurogenin3- and enteroendocrine-cells in patients with irritable bowel syndrome. BMC Gastroenterology, Submitted. 2016.
   Google Scholar
• Wang J, Cortina G, Wu SV, et al. Mutant neurogenin-3 in congenital malabsorptive diarrhea. N Engl J Med. 2006;355:270–280.
   PubMed Web of Science ®Google Scholar
• Fishbein TM, Novitskiy G, Lough DM, et al. Rejection reversibly alters enteroendocrine cell renewal in the transplanted small intestine. Am J Transplant. 2009;9:1620–1628.
   PubMed Web of Science ®Google Scholar
• Jenny M, Uhl C, Roche C, et al. Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. Embo J. 2002;21:6338–6347.
   PubMed Web of Science ®Google Scholar
• Svendsen B, Holst JJ. Regulation of gut hormone secretion. Studies using isolated perfused intestines. Peptides. 2016;77:47–53.
   PubMed Web of Science ®Google Scholar
• Svendsen B, Pedersen J, Albrechtsen NJ, et al. An analysis of cosecretion and coexpression of gut hormones from male rat proximal and distal small intestine. Endocrinology. 2015;156:847–857.
   PubMed Web of Science ®Google Scholar
• Egerod KL, Engelstoft MS, Grunddal KV, et al. A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin. Endocrinology. 2012;153:5782–5795.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Wendelbo I, Gundersen D. Serotonin and serotonin transporter in the rectum of patients with irritable bowel disease. Mol Med Rep. 2013;8:451–455.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Vaali K, Dizdar V, et al. Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome. Dig Dis Sci. 2010;55:3508–3513.
   PubMed Web of Science ®Google Scholar
• Coleman NS, Foley S, Dunlop SP, et al. Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease. Clin Gastroenterol Hepatol. 2006;4:874–881.
   PubMed Web of Science ®Google Scholar
• Dunlop SP, Coleman NS, Blackshaw E, et al. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005;3:349–357.
   PubMed Web of Science ®Google Scholar
• Dunlop SP, Jenkins D, Neal KR, et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 2003;125:1651–1659.
   PubMed Web of Science ®Google Scholar
• Lee KJ, Kim YB, Kim JH, et al. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol. 2008;23:1689–1694.
   PubMed Web of Science ®Google Scholar
• Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000;47:804–811.
   PubMed Web of Science ®Google Scholar
• Kim HS, Lim JH, Park H, et al. Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection–an observation in a small case control study. Yonsei Med J. 2010;51:45–51.
   PubMed Web of Science ®Google Scholar
• Whorwell PJ, McCallum M, Creed FH, et al. Non-colonic features of irritable bowel syndrome. Gut. 1986;27:37–40.
   PubMed Web of Science ®Google Scholar
• Kanazawa M, Endo Y, Whitehead WE, et al. Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress. Dig Dis Sci. 2004;49:1046–1053.
   PubMed Web of Science ®Google Scholar
• Locke GR 3rd, Zinsmeister AR, Talley NJ, et al. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc. 2000;75:907–912.
   PubMed Web of Science ®Google Scholar
• Kalantar JS, Locke GR 3rd, Zinsmeister AR, et al. Familial aggregation of irritable bowel syndrome: a prospective study. Gut. 2003;52:1703–1707.
   PubMed Web of Science ®Google Scholar
• Saito YA, Petersen GM, Larson JJ, et al. Familial aggregation of irritable bowel syndrome: a family case-control study. Am J Gastroenterol. 2010;105:833–841.
   PubMed Web of Science ®Google Scholar
• Saito YA. Genes and irritable bowel syndrome: is there a link? Curr Gastroenterol Rep. 2008;10:355–362.
   PubMedGoogle Scholar
• Waehrens R, Ohlsson H, Sundquist J, et al. Risk of irritable bowel syndrome in first-degree, second-degree and thirddegree relatives of affected individuals: a nationwide family study in Sweden. Gut. 2014;64:215–221.
   PubMed Web of Science ®Google Scholar
• Morris-Yates A, Talley NJ, Boyce PM, et al. Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol. 1998;93:1311–1317.
   PubMed Web of Science ®Google Scholar
• Levy RL, Jones KR, Whitehead WE, et al. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology. 2001;121:799–804.
   PubMed Web of Science ®Google Scholar
• Ford AC, Moayyedi P, Lacy BE, et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 2014;109(Suppl 1):S2–26; quiz S27.
   Google Scholar
• Bengtson MB, Ronning T, Vatn MH, et al. Irritable bowel syndrome in twins: genes and environment. Gut. 2006;55:1754–1759.
   PubMed Web of Science ®Google Scholar
• D’Amato M. Genes and functional GI disorders: from casual to causal relationship. Neurogastroenterol Motil. 2013;25:638–649.
   PubMed Web of Science ®Google Scholar
• Camilleri M. Serotonin in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2009;16:53–59.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Katzka DA. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012;302:G1075–G1084.
   PubMed Web of Science ®Google Scholar
• Saito YA. The role of genetics in IBS. Gastroenterol Clin North Am. 2011;40:45–67.
   PubMed Web of Science ®Google Scholar
• Camilleri M. Genetics of human gastrointestinal sensation. Neurogastroenterol Motil. 2013;25:458–466.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Gundersen D, Hatlebakk JG, et al. Diet and irritable bowel syndrome, with a focus on appetite-regulating hormones. In: Watson RR, editor. Nutrition in the prevention and treatment of abdominal obesity. San Diego: Elsevier; 2014. p. 5–16.
   Google Scholar
• Mazzawi T, El-Salhy M. Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidance. Int J Mol Med. 2016;37:1247–1253.
   PubMed Web of Science ®Google Scholar
• Mazzawi T, El-Salhy M. Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome. Exp Ther Med. 2016;12:1398–1404.
   PubMed Web of Science ®Google Scholar
• Mazzawi T, Gundersen D, Hausken T, et al. Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome. Mol Med Rep. 2014;10:2322–2326.
   PubMed Web of Science ®Google Scholar
• Mazzawi T, Gundersen D, Hausken T, et al. Increased chromogranin A cell density in the large intestine of patients with irritable bowel syndrome after receiving dietary guidance. Gastrointestinal Res Pract. 2015;2015:823897. DOI:10.1155/2015/823897
   PubMed Web of Science ®Google Scholar
• Mazzawi T, Hausken T, Gundersen D, et al. Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome. Eur J Clin Nutr. 2016;70:175–181.
   PubMed Web of Science ®Google Scholar
• Mazzawi T, Lied G, El-Sahy M, et al. Effect of fecal transplantation on the symptoms and duodenal endocrine cells in patients with irritable bowel syndrome. United European Gastroenterol J. 2016;4(Suppl 5):677–677.
   PubMed Web of Science ®Google Scholar
• El-Salhy M. Recent advances in the diagnosis of irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2015;9:1161–1174.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Umezawa K, Hatlebakk JG, et al. Abnormal differentiation of stem cells into enteroendocrine cells in rats with DSS-induced colitis. Mol Med. Forthcoming 2016.
   Web of Science ®Google Scholar
• May CL, Kaestner KH. Gut endocrine cell development. Mol Cell Endocrinol. 2010;323:70–75.
   PubMed Web of Science ®Google Scholar
• Gunawardene AR, Corfe BM, Staton CA. Classification and functions of enteroendocrine cells of the lower gastrointestinal tract. Int J Exp Pathol. 2011;92:219–231.
   PubMed Web of Science ®Google Scholar
• Camilleri M. Peripheral mechanisms in irritable bowel syndrome. N Engl J Med. 2012;367:1626–1635.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Lasch K, Zhou W. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012;303:G775–G785.
   PubMed Web of Science ®Google Scholar
• Camilleri M. Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms. J Physiol. 2014;592:2967–2980.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Norrgard O. Colonic neuroendocrine peptide levels in patients with chronic idiopathic slow transit constipation. Ups J Med Sci. 1998;103:223–230.
   PubMed Web of Science ®Google Scholar
• Sood R, Gracie DJ, Law GR, et al. Systematic review with meta-analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers. Aliment Pharmacol Ther. 2015;42:491–503.
   PubMed Web of Science ®Google Scholar
• Sjolund K, Fasth S, Ekman R, et al. Neuropeptides in idiopathic chronic constipation (slow transit constipation). Neurogastroenterol Motil. 1997;9:143–150.
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Norrgard O, Spinnell S. Abnormal colonic endocrine cells in patients with chronic idiopathic slow-transit constipation. Scand J Gastroenterol. 1999;34:1007–1011.
   PubMed Web of Science ®Google Scholar
• Quigley EM. Prucalopride: safety, efficacy and potential applications. Therap Adv Gastroenterol. 2012;5:23–30.
   PubMed Web of Science ®Google Scholar
• Tack J, Camilleri M, Chang L, et al. Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther. 2012;35:745–767.
   PubMed Web of Science ®Google Scholar
• Ke M, Zou D, Yuan Y, et al. Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study. Neurogastroenterol Motil. 2012;24:999–e541.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Van Outryve MJ, Beyens G, et al. Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies. Aliment Pharmacol Ther. 2010;32:1113–1123.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Beyens G, Kerstens R, et al. Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study. Neurogastroenterol Motil. 2009;21:1256–e1117.
   PubMed Web of Science ®Google Scholar
• Quigley EM, Vandeplassche L, Kerstens R, et al. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation–a 12-week, randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2009;29:315–328.
   PubMed Web of Science ®Google Scholar
• Garrigues V, Mearin F, Badia X, et al. Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study). Aliment Pharmacol Ther. 2007;25:323–332.
   PubMed Web of Science ®Google Scholar
• Drossman DA, Morris CB, Hu Y, et al. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology. 2005;128:580–589.
   PubMed Web of Science ®Google Scholar